Synaptic vesicle mimics affect the aggregation of wild-type and A53T α-synuclein variants differently albeit similar membrane affinity.

Related Articles:

• Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease. October 22, 2019 Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease. Commun Biol. 2019;2:374 Authors: de Oliveira GAP, Silva JL Abstract Amyloid formation is a process involving interconverting protein species and results in toxic oligomers and fibrils. Aggregated alpha-synuclein (αS) participates in neurodegenerative maladies, but a closer understanding of the early αS polymerization stages and polymorphism of heritable…
• α-Synuclein aggregation at low concentrations. May 17, 2019 α-Synuclein aggregation at low concentrations. Biochim Biophys Acta Proteins Proteom. 2019 May 13;: Authors: Afitska K, Fucikova A, Shvadchak VV, Yushchenko DA Abstract BACKGROUND: Aggregation of the neuronal protein α-synuclein into amyloid fibrils is a hallmark of Parkinson's disease. The propensity of α-synuclein to aggregate increases with the protein concentration. For the development of efficient inhibitors of α-synuclein aggregation, it…
• Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control. April 18, 2019 Related ArticlesQuantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control. Cell Rep. 2019 Apr 16;27(3):916-927.e5 Authors: Perrino G, Wilson C, Santorelli M, di Bernardo D Abstract Aggregation of α-synuclein and formation of inclusions are hallmarks of Parkinson's disease (PD). Aggregate formation is affected by cellular environment, but it has been studied almost exclusively in cell-free systems.…
• α-Synuclein dimers as potent inhibitors of fibrillization. October 19, 2019 α-Synuclein dimers as potent inhibitors of fibrillization. J Med Chem. 2019 Oct 18;: Authors: Kyriukha YA, Afitska K, Kurochka AS, Sachan S, Galkin M, Yushchenko DA, Shvadchak VV Abstract Aggregation of the neuronal protein α-synuclein into amyloid fibrils plays a central role in the development of Parkinson's disease. Growth of fibrils can be suppressed by blocking fibril ends from their…
• Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification. August 3, 2019 Related ArticlesSeeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification. FASEB J. 2019 Aug 01;:fj201900354R Authors: Nicot S, Verchère J, Bélondrade M, Mayran C, Bétemps D, Bougard D, Baron T Abstract α-Synuclein (α-syn) protein aggregation is associated with several neurodegenerative disorders collectively referred to as synucleinopathies, including Parkinson's disease. We used protein misfolding cyclic amplification (PMCA)…
• Membrane interactions of intrinsically disordered proteins: The example of alpha-synuclein. May 17, 2019 Membrane interactions of intrinsically disordered proteins: The example of alpha-synuclein. Biochim Biophys Acta Proteins Proteom. 2019 May 13;: Authors: Das T, Eliezer D Abstract Peripheral membrane proteins associate reversibly with biological membranes that, compared to protein binding partners, are structurally labile and devoid of specific binding pockets. Membranes in different subcellular compartments vary primarily in their chemical composition and physical…
• Deciphering the anti-Parkinson's activity of sulfated polysaccharides from Chlamydomonas reindertaii on the a-synuclein mutants A30P, A53T, E46K, E57K and E35K. August 7, 2019 Deciphering the anti-Parkinson's activity of sulfated polysaccharides from Chlamydomonas reindertaii on the a-synuclein mutants A30P, A53T, E46K, E57K and E35K. J Biochem. 2019 Aug 06;: Authors: Panigrahi GP, Rane AR, Vavilala SL, Choudhary S Abstract Parkinsonism-linked mutations in alanine and glutamic acid residues of the pre-synaptic protein α-Synuclein affect specific tertiary interactions essential for stability of the native state and…
• E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity. May 3, 2019 E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity. J Biol Chem. 2019 May 02;: Authors: Rovere M, Powers AE, Jiang H, Pitino JC, Fonseca-Ornelas L, Patel DS, Achille A, Langen R, Varkey J, Bartels T Abstract Parkinson's disease (PD) is one of the most common neurodegenerative disorders and both genetic and histopathological evidence have implicated the ubiquitous presynaptic…
• Immobilization approaches can affect protein dynamics: a surface-enhanced infrared spectroscopic study on lipid-protein interactions. May 31, 2019 Related ArticlesImmobilization approaches can affect protein dynamics: a surface-enhanced infrared spectroscopic study on lipid-protein interactions. Biomater Sci. 2019 May 31;: Authors: Fallah MA, Hauser K Abstract The intrinsically disordered Parkinson disease protein α-synuclein (αS) performs conformational changes induced by intermolecular protein-protein as well as by protein-membrane interactions. Aggregation of αS is a hallmark for the disease, however the role of…
• Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease. May 30, 2019 Related ArticlesNitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson's Disease. Adv Exp Med Biol. 2019;1127:169-179 Authors: Chavarría C, Trostchansky A, Durán R, Rubbo H, Souza JM Abstract α-Synuclein (α-syn) represents the main component of the amyloid aggregates present in Parkinson's disease and other neurodegenerative disorders, collectively named synucleinopathies. Although α-syn is considered a natively unfolded protein, it shows great…
• Structure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region. March 23, 2019 Related ArticlesStructure and dynamics of the extended-helix state of alpha-synuclein: Intrinsic lability of the linker region. Protein Sci. 2018 07;27(7):1314-1324 Authors: Sung YH, Eliezer D Abstract The Parkinson's protein alpha-synuclein binds to synaptic vesicles in vivo and adopts a highly extended helical conformation when binding to lipid vesicles in vitro. High-resolution structural analysis of alpha-synuclein bound to small lipid or…
• The Physiological Role of α-Synuclein and Its Relationship to Parkinson's Disease. July 4, 2019 The Physiological Role of α-Synuclein and Its Relationship to Parkinson's Disease. J Neurochem. 2019 Jul 03;: Authors: Sulzer D, Edwards RH Abstract The protein α-synuclein has a central role in the pathogenesis of Parkinson's disease (PD). In this review, we discuss recent results concerning its primary function, which appears to be on cell membranes. The presynaptic location of synuclein has…
• Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor… June 9, 2019 Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment. Free Radic Biol Med. 2019 Jun 05;: Authors: Maki RA, Holzer M, Motamedchaboki K, Malle E, Masliah E, Marsche G, Reynolds WF Abstract α-Synuclein (αSyn) is central…
• An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils. August 8, 2019 Related ArticlesAn engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils. Elife. 2019 Aug 07;8: Authors: Agerschou ED, Flagmeier P, Saridaki T, Galvagnion C, Komnig D, Heid L, Prasad V, Shaykhalishahi H, Willbold D, Dobson CM, Voigt A, Falkenbürger B, Hoyer W, Buell AK Abstract Removing or preventing the formation of α-synuclein aggregates is a plausible strategy…
• Engineered Protein Binds to Alpha-synuclein to Prevent Toxic Clumping, Study Reports September 9, 2019 An engineered protein known as AS69 is able to bind to individual units of alpha-synuclein to prevent them from clumping, and — in a fly model of Parkinson’s disease — its use led to preserved motor function, a study reports. The study, “An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils,” appeared in the journal eLIFE. Cellular…
• Partially oxidized DJ-1 inhibits α-synuclein nucleation and remodels mature α-synuclein fibrils in vitro. November 9, 2019 Related ArticlesPartially oxidized DJ-1 inhibits α-synuclein nucleation and remodels mature α-synuclein fibrils in vitro. Commun Biol. 2019;2:395 Authors: Kumar R, Kumar S, Hanpude P, Singh AK, Johari T, Majumder S, Maiti TK Abstract DJ-1 is a deglycase enzyme which exhibits a redox-sensitive chaperone-like activity. The partially oxidized state of DJ-1 is active in inhibiting the aggregation of α-synuclein, a key protein…
• Lipid membranes influence the ability of small molecules to inhibit huntingtin fibrillization. October 15, 2019 Lipid membranes influence the ability of small molecules to inhibit huntingtin fibrillization. Biochemistry. 2019 Oct 14;: Authors: Beasley M, Stonebraker A, Hasan I, Kapp KL, Liang BJ, Agarwal G, Groover S, Sedighi F, Legleiter J Abstract Several diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease (HD), are associated with specific proteins aggregating and depositing within tissues and/or cellular compartments.…
• Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling. May 22, 2019 Related ArticlesFunctional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling. Proc Natl Acad Sci U S A. 2019 May 20;: Authors: Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER, Roy S Abstract The function of α-synuclein (α-syn) has been long debated, and two seemingly divergent views have emerged. In one, α-syn binds to VAMP2, acting…
• Characterizing the inhibition of α-synuclein oligomerisation by a pharmacological chaperone that prevents prion formation by the protein PrP. July 16, 2019 Characterizing the inhibition of α-synuclein oligomerisation by a pharmacological chaperone that prevents prion formation by the protein PrP. Protein Sci. 2019 Jul 15;: Authors: Dong C, Garen CR, Mercier P, Petersen NO, Woodside MT Abstract Aggregation of the disordered protein α-synuclein into amyloid fibrils is a central feature of synucleinopathies, neurodegenerative disorders that include Parkinson's disease. Small, pre-fibrillar oligomers of…
• Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein. October 6, 2019 Related ArticlesAdvances in the development of imaging probes and aggregation inhibitors for alpha-synuclein. Acta Pharmacol Sin. 2019 Oct 04;: Authors: Xu MM, Ryan P, Rudrawar S, Quinn RJ, Zhang HY, Mellick GD Abstract Abnormal protein aggregation has been linked to many neurodegenerative diseases, including Parkinson's disease (PD). The main pathological hallmark of PD is the formation of Lewy bodies (LBs)…